News Center

A modern veterinary drug GMP pharmaceutical enterprise relying on high technology, integrating scientific research, development, production, sales and service

Enterprise News

Technical Data

Industry dynamics

Home page

Shandong Chinese Veterinary Medicine Association Enters Zhongren-Seminar on How to Enter, Open, Expand and Strengthen the Chinese Veterinary Drug Market

Release time:

2023-03-07

On the morning of March 4, 2023, Executive Director of Shandong Veterinary Association, President of Chinese Veterinary BranchHan WendengLeading the vice president of Shandong Veterinary Association· Honorary President of Chinese Veterinary Medicine BranchYang Zhiqiang,Executive Director of Shandong Veterinary Association• Deputy Secretary-GeneralLi Yungang, Wang Xin, Li Xiangan, Chen Daquan, Li Kexin, Li Lianjie, Li Meifeng, Lin ShaganOne line10 people came.Qingdao Zhongren Animal Medicine Co., LtdVisit, study, discussion and exchange.

Site Visit

8:30 a.m. Shandong Chinese Veterinary Medicine AssociationHan WendengA party in Qingdao Zhongren Group ChairmanZhang Shurenand the company's vice president of salesLi HuaVice President of Quality ResearchLi JinxiangVice President of ProductionWu TongAccompanied by a visit to the factory and production workshop. Experts on the company's advanced equipment and technology to give a high degree of recognition.

Seminar

Shandong Veterinary AssociationExperts from the Chinese Veterinary Branch held a seminar on how to enter, open, expand and strengthen the Chinese veterinary drug market in the conference room on the second floor of the R & D building of Qingdao Zhongren Animal Drug Co., Ltd. Chairman Zhang Shuren, Vice President of Sales Li Hua, Vice President of Quality Research Li Jinxiang, Vice President of Production Wu Tong, Deputy Director of Research and Development Li Qinfang and other department leaders and relevant staff attended the meeting.

Chairman Zhang Shuren welcomed the visit of the leaders and experts of the association, and introduced in detail the company's development history and future development plans. Li Jinxiang, vice president of quality research, introduced the company's Chinese medicine number. At the meeting, experts discussed the problems in the new product declaration and gave corresponding suggestions.

President Yang Zhiqiang made a detailed interpretation of the current policies and regulations of the veterinary drug industry, and put forward valuable opinions on the company's production process improvement, new product research and development, and product quality.

Secretary-General Li Yungang introduced the member enterprises of the association and the role of the association in the development of the enterprise. And affirmed the development direction of the company, hoping that we can achieve strong enterprises, strong science and technology, strong talents, strong industrial resilience, strong industrial chain.

Other experts attending the meeting also gave our company a high degree of affirmation and blessing, and gave examples on the problems encountered in the development of our enterprise, such as raw material procurement, sales, how to improve and improve the products on the basis of specialization, so as to avoid using for reference when we encounter the same problems in the future and avoid detours.

President Han Wendeng put forward unique development ideas on the advantages, development prospects, and development and utilization directions of Chinese veterinary medicine. Make guiding suggestions on enterprise management and the application of sales, research and development, quality inspection talents.